NEW YORK, June 20, 2023 /PRNewswire/ — Levi & Korsinsky notifies investors that it has commenced an investigation of Travere Therapeutics, Inc. (“Travere”) (NASDAQ: TVTX) concerning possible violations of federal securities laws. The investigation focuses on whether Travere issued false…